ISRCTN15253766已完成不适用
Exploring the therapeutic potential of xanthine oxidase inhibitor allopurinol in angina
niversity of Dundee (UK)0 个研究点目标入组 88 人开始时间: 2006年3月29日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Documented coronary artery disease
- •2. Chronic stable angina
排除标准
- •1. Left ventricular systolic dysfunction
- •2. Renal failure
- •3. Concomitant warfarin therapy
- •4. Allergy to allopurinol
研究者
相似试验
进行中（未招募）
1 期
EXPLORING THE THERAPEUTIC POTENTIAL OF XANTHINE OXIDASE INHIBITORS IN CORONARY ARTERY DISEASE - allopurinol in CADIshaemic heart diseaseAngina, acute myocardial infarctionEUCTR2005-003081-42-GBniversity of DUndee124
尚未招募
不适用
Treatment of Oral Submucous Fibrosis with Xanthinol Nicotinate, Dexamethasone and Levamisole.CTRI/2019/05/019008Dr Shaikh Saba Sultana
进行中（未招募）
1 期
Allopurinol, brain lesions, heart size and blood pressure after ischaemic strokeEUCTR2013-004235-77-GBHS Greater Glasgow & Clyde464
已完成
不适用
Do Xanthine Oxidase Inhibitors (XOI) have clinically useful anti-ischaemic effects in the treatment of angina pectoris? A double-blind, placebo controlled trialCoronary Artery Disease - patients with chronic stable anginaCirculatory SystemCoronary Artery DiseaseISRCTN82040078niversity of Dundee (UK)60
招募中
3 期
Investigating the effect of quince oxymel on non-alcoholic fatty liveron-alcoholic fatty liver.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20221202056689N1Ghoum University of Medical Sciences80